세계의 의료 검체 추적 시스템 시장 : 제품별, 기술별, 검체 유형별, 최종사용자별, 지역별 평가, 기회와 예측(2018-2032년)

Global medical specimen tracking systems market is projected to witness a CAGR of 8.98% during the forecast period 2025-2032, growing from USD 1002.23 million in 2024 to USD 1994.08 million in 2032. The market's growth can be attributed to the rising number of clinical trials, the rising requirement for automation in laboratories to improve workflow and reduce human error, and advancements in tracking systems, including the integration of artificial intelligence (AI) and machine learning algorithms.

Additionally, the requirement for medical specimen tracking systems is also increasing to reduce the chances of misdiagnosis and medical errors. Tracking systems also aid medical professionals in ensuring that they are processed on time, as delays can result in a wide range of challenges that can jeopardize the results.

Moreover, as clinical research expands, the demand for efficient management, monitoring, transportation, collection, and analysis of biological specimens is increasing, propelling the market's demand. Clinical trials generate large volumes of specimens that often require meticulous tracking to ensure regulatory compliance and maintain coordination across different research sites. In such situations, tracking systems play a crucial role in handling complex logistics while minimizing errors in specimen handling and identification.

Increasing Requirement for Diagnostic Tests Boosts Market Demand

The rising reliance on diagnostic tests can be attributed to the growing burden of various chronic diseases and disorders in different regions across the globe. The American Cancer Society estimates that over 2 million new cancer cases will be reported in the United States in 2025. As medical professionals and laboratories handle complex testing processes and high sample volumes, the requirement for automated tracking systems to prevent misidentification and workflow management is rising. Medical specimen tracking systems aid laboratories in maintaining sample integrity, ensuring the delivery of results in a time-efficient manner with the help of automated alerts and real-time location tracking, and reducing the risk of contamination. Additionally, digital health initiatives and government-backed healthcare modernization programs are pushing hospitals to adopt these systems to meet regulatory compliance and improve patient safety outcomes.

Rising Emphasis on Laboratory Automation Supports Market Expansion

Laboratories are increasingly seeking automated solutions to streamline sample collection, transport, and analysis processes. Medical specimen tracking systems have become essential for supporting automation in clinical labs by ensuring every sample is accurately logged, located, and matched with the right patient data. These systems reduce manual errors, minimize sample losses, and improve staff productivity. Technological advancements, such as integration with laboratory information systems (LIS), real-time dashboards, and mobile apps, are making specimen tracking more accessible and scalable across varied healthcare settings. Automated sample tracking helps laboratories meet the increasing demand for high-throughput testing. As testing capacities scale up, laboratories require reliable systems to maintain quality and traceability.

Furthermore, regulatory authorities such as the United States Food and Drug Administration (US FDA) and the European Medicines Agency emphasize the need for secure and verifiable chain-of-custody procedures, further prompting the adoption of automated specimen tracking systems. Thus, leading companies are investing in research and development to introduce intelligent specimen-tracking software equipped with predictive analytics, AI-based sorting mechanisms, and real-time audit trails. For instance, in January 2023, Becton, Dickinson and Company launched a new robotic track system to support flexible and custom lab automation configuration to meet the unique and evolving requirements of laboratories.

RFID-Based Tracking Systems Account for Significant Share of the Market

RFID systems offer significant advantages over traditional barcoding, such as improved read rates, automation of inventory tracking, and the ability to track multiple specimens simultaneously without direct line-of-sight, supporting the segment's expansion. These benefits are particularly valuable in large-scale hospital and laboratory environments where speed, accuracy, and sample security are critical. RFID-enabled tracking also supports temperature monitoring during specimen transport, which is vital for preserving the integrity of sensitive biological samples. Additionally, the relatively low costs of RFID tags and readers are making technology more accessible to mid-sized and smaller healthcare institutions.

Due to the rising requirements for RFID-based systems, the leading players in the market are focusing on launching new solutions to meet the different requirements of the healthcare and life science sectors. For instance, in March 2024, TMRW Life Sciences, Inc. launched a new digital specimen management system that contains an RFID tracking chip and intuitive specimen management software to provide a unique off-site storage experience.

North America Holds a Major Market Share

The rapid growth of the market in North America can be attributed to the presence of leading market players and well-established healthcare industry, stringent regulatory requirements for specimen handling, and early adoption of digital technologies by the healthcare sector. High investments in healthcare IT, along with increasing focus on patient safety and operational efficiency, are further driving the demand for advanced tracking solutions in clinical laboratories and hospitals across the United States and Canada. Additionally, the rise in the number of clinical trials and growing focus on research and development activities are also propelling the market's expansion in North America. As of 23rd May 2025, 158,176 studies are registered in the United States at ClinicalTrials.gov, the publicly available registry and results database, run by the National Library of Medicine (NLM) at the National Institutes of Health (NIH).

Future Market Scenario (2025-2032F)

The market is expected to witness significant growth over the forecast period due to rising awareness about patient safety and sample integrity, increasing diagnostic workload, and growing lab automation. The growing popularity of personalized medicines, the expansion of biobanks, and the increase in complex sample workflows in clinical trials are expected to propel the market's demand.

Ongoing research and development activities in combination with strategic partnerships and collaborations between healthcare institutions, laboratories, and technology providers are expected to drive innovations and ensure the availability of technologically advanced solutions. The next generation of medical specimen tracking systems is going to be defined by improved user interface and blockchain-backed traceability solutions.

Key Players Landscape and Outlook

The key players in the market are investing in real-time tracking, cloud-based platforms, AI-powered solutions, and automation to improve the efficiency, accuracy, and security of specimen-tracking processes across diagnostic centers, hospitals, and laboratories. Several market players are participating in partnerships and collaborations and mergers and acquisitions to meet the rising demand for traceability solutions in the healthcare industry and expand their global footprint. For instance, in November 2023, Cryoport Systems, LLC acquired Bluebird Express, LLC to expand its global supply chain network. The acquisition is allowing Cryoport to improve its service coverage across the United States and foster innovations in specimen tracking solutions, allowing the company to expand its presence in the industry.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. Global Medical Specimen Tracking Systems Market Outlook, 2018-2032F

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Product
    • 5.2.1.1. Software
    • 5.2.1.2. Hardware
    • 5.2.1.3. Consumables
  • 5.2.2. By Technology
    • 5.2.2.1. Barcode
    • 5.2.2.2. RFID
    • 5.2.2.3. GPS
    • 5.2.2.4. Others
  • 5.2.3. By Specimen Type
    • 5.2.3.1. Patient Testing
    • 5.2.3.2. Clinical Trial
    • 5.2.3.3. Tissue Specimen
  • 5.2.4. By End-user
    • 5.2.4.1. Hospitals and Clinics
    • 5.2.4.2. Pathology Laboratories
    • 5.2.4.3. Others
  • 5.2.5. By Region
    • 5.2.5.1. North America
    • 5.2.5.2. Europe
    • 5.2.5.3. Asia-Pacific
    • 5.2.5.4. South America
    • 5.2.5.5. Middle East and Africa
  • 5.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
• 5.3. Market Map Analysis, 2024
  • 5.3.1. By Product
  • 5.3.2. By Technology
  • 5.3.3. By Specimen Type
  • 5.3.4. By End-user
  • 5.3.5. By Region

6. North America Medical Specimen Tracking Systems Market Outlook, 2018-2032F

• 6.1. Market Size Analysis & Forecast
  • 6.1.1. By Value
• 6.2. Market Share Analysis & Forecast
  • 6.2.1. By Product
    • 6.2.1.1. Software
    • 6.2.1.2. Hardware
    • 6.2.1.3. Consumables
  • 6.2.2. By Technology
    • 6.2.2.1. Barcode
    • 6.2.2.2. RFID
    • 6.2.2.3. GPS
    • 6.2.2.4. Others
  • 6.2.3. By Specimen Type
    • 6.2.3.1. Patient Testing
    • 6.2.3.2. Clinical Trial
    • 6.2.3.3. Tissue Specimen
  • 6.2.4. By End-user
    • 6.2.4.1. Hospitals and Clinics
    • 6.2.4.2. Pathology Laboratories
    • 6.2.4.3. Others
  • 6.2.5. By Country Share
    • 6.2.5.1. United States
    • 6.2.5.2. Canada
    • 6.2.5.3. Mexico
• 6.3. Country Market Assessment
  • 6.3.1. United States Medical Specimen Tracking Systems Market Outlook, 2018-2032F*
    • 6.3.1.1. Market Size Analysis & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share Analysis & Forecast
      • 6.3.1.2.1. By Product
        • 6.3.1.2.1.1. Software
        • 6.3.1.2.1.2. Hardware
        • 6.3.1.2.1.3. Consumables
      • 6.3.1.2.2. By Technology
        • 6.3.1.2.2.1. Barcode
        • 6.3.1.2.2.2. RFID
        • 6.3.1.2.2.3. GPS
        • 6.3.1.2.2.4. Others
      • 6.3.1.2.3. By Specimen Type
        • 6.3.1.2.3.1. Patient Testing
        • 6.3.1.2.3.2. Clinical Trial
        • 6.3.1.2.3.3. Tissue Specimen
      • 6.3.1.2.4. By End-user
        • 6.3.1.2.4.1. Hospitals and Clinics
        • 6.3.1.2.4.2. Pathology Laboratories
        • 6.3.1.2.4.3. Others
  • 6.3.2. Canada
  • 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Medical Specimen Tracking Systems Market Outlook, 2018-2032F

• 7.1. Germany
• 7.2. France
• 7.3. Italy
• 7.4. United Kingdom
• 7.5. Russia
• 7.6. Netherlands
• 7.7. Spain
• 7.8. Turkey
• 7.9. Poland

8. Asia-Pacific Medical Specimen Tracking Systems Market Outlook, 2018-2032F

• 8.1. India
• 8.2. China
• 8.3. Japan
• 8.4. Australia
• 8.5. Vietnam
• 8.6. South Korea
• 8.7. Indonesia
• 8.8. Philippines

9. South America Medical Specimen Tracking Systems Market Outlook, 2018-2032F

• 9.1. Brazil
• 9.2. Argentina

10. Middle East and Africa Medical Specimen Tracking Systems Market Outlook, 2018-2032F

• 10.1. Saudi Arabia
• 10.2. UAE
• 10.3. South Africa

11. Demand Supply Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

• 15.1. Market Drivers
• 15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Landscape and Innovation

18. Case Studies

19. Competitive Landscape

• 19.1. Competition Matrix of Top 5 Market Leaders
• 19.2. SWOT Analysis for Top 5 Players
• 19.3. Key Players Landscape for Top 10 Market Players
  • 19.3.1. BioIT Solutions, Inc.
    • 19.3.1.1. Company Details
    • 19.3.1.2. Key Management Personnel
    • 19.3.1.3. Products and Services
    • 19.3.1.4. Financials (As Reported)
    • 19.3.1.5. Key Market Focus and Geographical Presence
    • 19.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 19.3.2. Cryoport Systems, LLC
  • 19.3.3. Taylor Data Systems, Inc.
  • 19.3.4. NovoPath, Inc.
  • 19.3.5. RMS Omega Technologies
  • 19.3.6. GAO Group
  • 19.3.7. LabConnect, Inc.
  • 19.3.8. Peak Technologies LLC
  • 19.3.9. LabWare, Inc.
  • 19.3.10. STARLIMS Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

20. Strategic Recommendations

21. About Us and Disclaimer